CN100554956C - 一种丹参酮ⅱa磺酸钠的高效液相分析方法 - Google Patents
一种丹参酮ⅱa磺酸钠的高效液相分析方法 Download PDFInfo
- Publication number
- CN100554956C CN100554956C CNB2005100948433A CN200510094843A CN100554956C CN 100554956 C CN100554956 C CN 100554956C CN B2005100948433 A CNB2005100948433 A CN B2005100948433A CN 200510094843 A CN200510094843 A CN 200510094843A CN 100554956 C CN100554956 C CN 100554956C
- Authority
- CN
- China
- Prior art keywords
- phase
- sodium sulfonate
- tanshinone iia
- minutes
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007791 liquid phase Substances 0.000 title claims abstract description 13
- 238000004458 analytical method Methods 0.000 title claims abstract description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract description 8
- 239000011734 sodium Substances 0.000 title abstract description 8
- 229910052708 sodium Inorganic materials 0.000 title abstract description 8
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000012074 organic phase Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000010828 elution Methods 0.000 claims abstract description 9
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 239000012071 phase Substances 0.000 claims description 32
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 13
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 13
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical group [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 6
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 claims description 6
- 235000019837 monoammonium phosphate Nutrition 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical group [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 3
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 abstract description 31
- 239000000126 substance Substances 0.000 abstract description 20
- 238000002360 preparation method Methods 0.000 abstract description 19
- 239000002994 raw material Substances 0.000 abstract description 19
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 abstract description 13
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 abstract description 6
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 43
- 239000000047 product Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 239000003182 parenteral nutrition solution Substances 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 240000007164 Salvia officinalis Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 235000005412 red sage Nutrition 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- -1 diterpene compound Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100948433A CN100554956C (zh) | 2005-10-17 | 2005-10-17 | 一种丹参酮ⅱa磺酸钠的高效液相分析方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100948433A CN100554956C (zh) | 2005-10-17 | 2005-10-17 | 一种丹参酮ⅱa磺酸钠的高效液相分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1952656A CN1952656A (zh) | 2007-04-25 |
CN100554956C true CN100554956C (zh) | 2009-10-28 |
Family
ID=38059098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100948433A Active CN100554956C (zh) | 2005-10-17 | 2005-10-17 | 一种丹参酮ⅱa磺酸钠的高效液相分析方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100554956C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105223288A (zh) * | 2014-03-14 | 2016-01-06 | 上海上药第一生化药业有限公司 | 丹参酸甲酯磺酸钠的制备方法和应用 |
CN105301155B (zh) * | 2015-07-31 | 2017-11-24 | 复旦大学附属华山医院 | 一种测定人血浆中丹参酮iia磺酸钠浓度的方法 |
-
2005
- 2005-10-17 CN CNB2005100948433A patent/CN100554956C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1952656A (zh) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bai et al. | Determination of oligosaccharides and monosaccharides in Hakka rice wine by precolumn derivation high-performance liquid chromatography | |
CN110320290B (zh) | 甲钴胺注射液有关物质的hplc检测方法 | |
CN108279278B (zh) | 一种分离黄酮类成分的方法及其应用 | |
Xie et al. | Simultaneous determination of six main components in Bushen Huoxue prescription by HPLC-CAD | |
CN110057950B (zh) | 一种基于检测波长切换的蒲地蓝消炎片hplc指纹图谱的构建方法 | |
CN107543889B (zh) | 一种大株红景天胶囊指纹图谱及其构建方法 | |
CN100554956C (zh) | 一种丹参酮ⅱa磺酸钠的高效液相分析方法 | |
CN114252532B (zh) | 一种防风通圣颗粒指纹图谱的建立方法及其指纹图谱 | |
CN103630633A (zh) | 一种柱前衍生化法测定苦碟子注射液中6种氨基酸含量的方法 | |
Yang et al. | Simultaneous determination of eight active components in Chinese medicine ‘JiangYaBiFeng’tablet by HPLC coupled with diode array detection | |
Shah et al. | Analytical methods for furanochromone natural product, khellin and its inspired drug candidates, amiodarone and sodium cromoglycate | |
CN1853674B (zh) | 杏丹注射剂的检测方法 | |
CN113759056B (zh) | 一种半边莲及其制剂的特征图谱及其构建方法 | |
CN101721530A (zh) | 金鸡制剂的质量控制方法 | |
CN103513000A (zh) | 睡莲花的鉴别和含量测定方法 | |
CN110596263B (zh) | 一种辣木提取物指纹图谱的建立方法及其指纹图谱 | |
CN110274976B (zh) | 一种紫花杜鹃药材hplc指纹图谱构建方法 | |
CN106908542A (zh) | 清热止痒洗剂的质量检测方法 | |
Balamurugan et al. | Simultaneous chemo/enantioseparation and assay of R-(+)-rabeprazole and related impurities in pharmaceutical formulations | |
CN112843124A (zh) | 一种丹参配方颗粒的制备方法及其质量标准 | |
CN111830150B (zh) | 一测多评法测定新塔花中黄酮类成分含量的方法及其应用 | |
CN104007216B (zh) | 心脑宁胶囊的检测方法 | |
CN111077247A (zh) | 一种植物提取物或其制剂的检测方法 | |
CN100390161C (zh) | 羟基丹参酮ⅱa磺酸钠及其用途 | |
CN101301385B (zh) | 一种复方蛇胆陈皮散的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. Assignor: Qin Yinlin Contract record no.: 2010320001134 Denomination of invention: A high efficient liquid phase analysis method of sodium tanshinone IIA sulfonate Granted publication date: 20091028 License type: Exclusive License Open date: 20070425 Record date: 20100920 |
|
ASS | Succession or assignment of patent right |
Owner name: JIANGSU CAREFREE PHARMACEUTICAL CO., LTD. Effective date: 20120817 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120817 Address after: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee after: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. Address before: 210016 No. 323, Zhongshan East Road, Jiangsu, Nanjing 2 Patentee before: Qin Yinlin |
|
C56 | Change in the name or address of the patentee |
Owner name: JIANGSU CAREFREE MEDICINE CO., LTD. Free format text: FORMER NAME: JIANGSU CAREFREE PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee after: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Address before: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee before: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. Assignor: Qin Yinlin Contract record no.: 2010320001134 Date of cancellation: 20160613 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070425 Assignee: NANJING CAREPHAR SHENGHUI PHARMACEUTICAL Co.,Ltd. Assignor: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Contract record no.: 2016320000154 Denomination of invention: A high efficient liquid phase analysis method of sodium tanshinone IIA sulfonate Granted publication date: 20091028 License type: Exclusive License Record date: 20160617 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: NANJING CAREPHAR SHENGHUI PHARMACEUTICAL Co.,Ltd. Assignor: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Contract record no.: 2016320000154 Date of cancellation: 20161213 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070425 Assignee: NANJING CAREPHAR SHENGHUI PHARMACEUTICAL Co.,Ltd. Assignor: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Contract record no.: 2016320000241 Denomination of invention: A high efficient liquid phase analysis method of sodium tanshinone IIA sulfonate Granted publication date: 20091028 License type: Exclusive License Record date: 20161228 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: NANJING CAREPHAR SHENGHUI PHARMACEUTICAL Co.,Ltd. Assignor: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Contract record no.: 2016320000241 Date of cancellation: 20180814 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070425 Assignee: SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL Co.,Ltd. Assignor: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Contract record no.: 2018320000345 Denomination of invention: A high efficient liquid phase analysis method of sodium tanshinone IIA sulfonate Granted publication date: 20091028 License type: Exclusive License Record date: 20181127 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240403 Address after: Building 1, 7th Floor, No. 6 Xuzhuang Road, Xuanwu District, Nanjing City, Jiangsu Province, 210018 Patentee after: Jiangsu Kefeiping Pharmaceutical Sales Co.,Ltd. Country or region after: China Address before: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee before: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |